Pharma giant GSK is quitting industry group BIO
GSK is the fifth biopharma firm to depart BIO in roughly a year.
GSK is the fifth biopharma firm to depart BIO in roughly a year.
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
Europe needs to grow some teeth or risk being eaten by the world’s “carnivores,” says French president.
After a period of dominance by video conferences, a shift is underway and audio conferencing is experiencing a comeback. Learn more.
Despite widespread support for protecting abortion rights, voters said the cost of gas, housing, food, and health care was more important to their choice for…
A new study in rats led by Stanford Medicine researchers looked at whether ketamine’s effects depend on opioid pathways — and uncovered a surprising difference…
Harnessing the immune system for cancer therapies Ahmed Ahmed blends public policy with medicine to learn about the healthcare workforce. Read his story.
Watch this complimentary Gartner IT webinar to learn about the top strategic technology trends that you can use to keep your organization heading safely into…
Hear from local community health workers Madelin Martinez, MPH, Wilfredo (Wil) Torriente, and Latish Walker in a conversation presented by Dr. Lisa Cooper, Bloomberg Distinguished…
Structural and functional analyses identify a category of glycan-reactive antibodies in macaques and humans that are marked by the dimerization of the antigen-binding fragment. These…